|
PubMed list |
Paper inaccessible? |
|
PubMed list |
Paper inaccessible? |
2021
Hering NA, Luettig J, Jebautzke B, Schulzke JD, Rosenthal R (2021) The punicalagin metabolites ellagic acid and urolithin A exert different strengthening and anti-inflammatory effects on tight junction-mediated intestinal barrier function in vitro. Front. Pharmacol. 12: 610164, doi: 10.3389/fphar.2021.610164 (°IF 5.8)
2016-2017
Hering NA, Luettig J, Krug SM, Wiegand S, Gross G, van Tol EA, Schulzke JD*, Rosenthal R* (*shared last authorship) (2017) Lactoferrin protects against intestinal inflammation or bacteria-induced barrier dysfunction in vitro. Ann. N.Y. Acad. Sci. 1405: 177-188 (IF 4.3) [PubMed] [WebPage] [PDF]
Rosenthal R, Luettig J, Hering NA, Krug SM, Albrecht U, Fromm M, Schulzke JD (2017) Myrrh exerts barrier-stabilizing and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells. Int. J. Colorectal Dis. 32(5): 623-634 (IF 2.5) [PubMed] [WebPage] [PDF]
Luettig J, Rosenthal R, Lee IM, Krug SM, Schulzke JD (2016) The ginger component 6-shogaol prevents TNFα-induced barrier loss via inhibition of PI3K/Akt and NF-kB sigaling. Mol. Nutr. Food Res. 60(12): 2576-2586 (IF 4.3) [PubMed] [WebPage] [PDF]
2014-2015
Review
Luettig J, Rosenthal R, Barmeyer C, Schulzke JD (2015) Claudin-2 as mediator of leaky gut barrier during intestinal inflammation. Tiss. Barriers 3(1-2): e977176,
Published poster
Luettig J, Amasheh M, Rosenthal R, Fromm M, Schulzke JD (2014) Barrier-protective effects of the ginger constituent 6-shogaol in intestinal
epithelial cells (HT-29/B6). [Abstract] [Recommended by F1000]
2012
Amasheh M, Luettig J, Amasheh S, Zeitz M, Fromm M, Schulzke JD (2012) Effects of quercetin on the colonic cell culture model HT-29/B6 and rat intestine in vitro. Ann. N.Y. Acad. Sci. 1258: 100-107 (IF 4.4) [PubMed] [WebPage] [PDF] (Original paper)
Theses
